Literature DB >> 2792303

Trypanosoma brucei brucei: expression of drug resistance in vitro.

R Kaminsky1, F Chuma, E Zweygarth.   

Abstract

The susceptibility of five Trypanosoma brucei brucei stocks to diminazene aceturate (Berenil) and isometamidium chloride (Samorin) was determined in vivo and in vitro. Two stocks were resistant in mice to both drugs. Differences in drug-induced growth inhibition occurred between drug-resistant and drug-sensitive stocks when trypanosome bloodstream forms were incubated for 24 hr at 37 degrees C in 4% CO2 in air in a feeder layer-free culture system. Diminazene concentrations which inhibited growth of trypanosomes by 50% (EC50) differed more than 50-fold between drug-resistant and drug-sensitive stocks, but there were only minor differences in EC50 values for isometamidium. However, differences in growth inhibition due to isometamidium occurred when trypanosomes were incubated with drug concentrations (0.001-0.05 micrograms/ml) below the EC50 values. Trypanosome stocks which were propagated in vitro in the presence of drugs for a period of 10 days greatly differed in their viability. In contrast to drug-sensitive trypanosomes, drug-resistant stocks could be maintained without loss of viability in the presence of 0.01 micrograms/ml isometamidium chloride.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792303     DOI: 10.1016/0014-4894(89)90074-x

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  10 in total

1.  In vitro assessment of isometamidium chloride susceptibility of Trypanosoma vivax bloodstream forms.

Authors:  E Zweygarth; R Kaminsky; M A Gray
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  A new photometric assay for testing trypanocidal activity in vitro.

Authors:  J Zinsstag; R Brun; M Gessler
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.

Authors:  R Brun; Y Bühler; U Sandmeier; R Kaminsky; C J Bacchi; D Rattendi; S Lane; S L Croft; D Snowdon; V Yardley; G Caravatti; J Frei; J Stanek; H Mett
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.

Authors:  M Iten; H Mett; A Evans; J C Enyaru; R Brun; R Kaminsky
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.

Authors:  Marcel Kaiser; Michael A Bray; Monica Cal; Bernadette Bourdin Trunz; Els Torreele; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

6.  Trypanosoma congolense: the in vitro akinetoplastic induction sensitivity assay.

Authors:  H Chitambo; A Arakawa
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

7.  In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species.

Authors:  R Kaminsky; R Brun
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  The effect of isometamidium chloride on insect forms of drug-sensitive and drug-resistant stocks of Trypanosoma vivax: studies in vitro and in tsetse flies.

Authors:  R Kaminsky; F Chuma; E Zweygarth; D S Kitosi; S K Moloo
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

9.  Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal.

Authors:  Anne J N Kazibwe; Barbara Nerima; Harry P de Koning; Pascal Mäser; Michael P Barrett; Enock Matovu
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

10.  Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.

Authors:  Fabrice E Graf; Philipp Ludin; Tanja Wenzler; Marcel Kaiser; Reto Brun; Patient Pati Pyana; Philippe Büscher; Harry P de Koning; David Horn; Pascal Mäser
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.